| Execution period | 36 months from the effective date of 2026-11-05 |
|---|
NSE filing, NSE: CEIGALL. Summary written from the filing by ALFA Finder's alert engine.
Ceigall India Ltd: key numbers
- Share price
- ₹384.50
- Market cap
- ₹6,698 Cr
- Revenue (annual)
- ₹4,022 Cr
- Net profit (annual)
- ₹311.9 Cr
- P/E (TTM)
- 20.9×Sector 32.7×
- Promoter holding
- 82.06%+0.00% QoQ
- FII holding
- 3.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ceigall India Ltd
All →Ceigall India Earnings Call Transcript: Key Takeaways
Strong Q2 FY27: consolidated revenue ₹1,022.5 Cr (+26.8%), PAT ₹92.2 Cr (+64.1%). Growth guidance met, but H1 operating cash flow was negative.
- Call
- Guides 15% growth
Ceigall India Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹10,225Mn (+26.8%), PAT ₹922Mn (+64.1%), EBITDA margin 17.0%. Record order book ₹226,811Mn; HAM monetisation and entry into transmission.
Ceigall India Results Update
Ceigall India's H1 FY27 consolidated revenue rose 21.1% to INR 19,921 million, with PAT up 45%. The order book reached INR 2,26,811 million as of September 30.
Ceigall India Q2 FY27 Results: Net Profit ₹92.2 Cr, Up 64.1% YoY
Ceigall India Ltd reported revenue from operations of ₹1,022 Cr (+26.8% YoY) and net profit of ₹92.2 Cr (+64.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹92.2 Cr · +64.1% YoY
Ceigall India Merger & Restructuring Worth ₹86.32 Cr
Ceigall India Ltd will infuse Rs. 86.32 Crore into its step-down subsidiary, Ceigall Ambala Chandigarh Zirakpur Limited. The investment supports a 6-lane spur connectivity highway project in Punjab.
- Value
- ₹86.32 Cr
- highway length
- 10.3 Km
Ceigall India Board Meeting Date
Ceigall India has scheduled its Board meeting for 5 November 2026 to consider and approve Q1/H1 FY27 unaudited financial results. The trading window for insiders is closed from 1 October 2026 until results declaration.
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.